Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania, and Medidata AI.
Some weight loss influencers on TikTok have been banned after talking about GLP-1 medications including Novo Nordisk’s Wegovy and Ozempic and Eli Lilly’s Mounjaro. About
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS